McDermott International (MDR) 3.29 $MDR McDermott to

New Post Public Reply Private Reply Replies (0) Message Board

Mar 22, 2015 at 12:29 AM

McDermott International (MDR) 3.29 $MDR

McDermott to Participate at Investor Conference
Business Wire - Fri Mar 20, 1:25PM CDT
McDermott International, Inc. (NYSE: MDR) ("McDermott"

announced that David Dickson, President and Chief Executive Officer, will present at Howard Weil's Energy Conference in New Orleans, Louisiana on March 24, 2015 at 11:35 a.m. Central time. McDermott will post the slides to be used prior to the presentation at www.mcdermott.com in the investor relations section.
MDR: 3.29 (+0.01)

Volatility in the Short Term could lead to Rewards in the Long Run: McDermott International Analyst Brief Report Issued by BrokerBank Securities, Inc.
PR Newswire - Thu Mar 12, 6:00AM CDT
McDermott International Inc. (NYSE: MDR) based in Houston, TX, a leader in offshore infrastructure solutions to drilling services for the oil sector recently announced its 2014 Q4 earnings. McDermott showed a 56% jump in revenues compared to 2013 Q4, a 6.5% decrease in total costs from the year-ago quarter and a better than anticipated $0.32 loss per share following one of the worst six month periods for the oil price.
MDR: 3.29 (+0.01)

McDermott International - A 'Strong Sell' Despite Strong Q4 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 04, 1:50PM CST
Lack of visibility on the company's earnings and revenue growth, plus the weak award environment are big near-term concerns for McDermott International Inc. (MDR).
VLP: 52.94 (+0.15), WGP: 60.99 (+0.57), MDR: 3.29 (+0.01), VTTI: 25.12 (+0.31)

McDermott (MDR) Stock Rallies Today as WTI Rebounds
at The Street - Wed Mar 04, 1:50PM CST
Shares of McDermott International (MDR) are rallying in afternoon trading today as West Texas Intermediate crude rebounds.
MDR: 3.29 (+0.01)

Why McDermott International's Shares Popped 33% Today
Travis Hoium, The Motley Fool - Motley Fool - Tue Mar 03, 11:52AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of energy construction company McDermott...
MDR: 3.29 (+0.01)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Tue Mar 03, 11:45AM CST

MDR: 3.29 (+0.01), PRIM: 17.52 (unch), ANY: 4.56 (-0.30), NTRI: 20.56 (+0.45), EVDY: 12.37 (-0.33), STKL: 11.01 (+0.50), OPWR: 10.65 (+0.14), JOB: 0.92 (-0.04), DRRX: 1.68 (-0.01), LL: 28.51 (-0.84), KOSS: 2.48 (-0.01), ELRC: 10.21 (-0.20), TSRI: 4.85 (+0.05), OREX: 7.19 (-0.41), CYCC: 0.98 (+0.02), URRE: 1.42 (+0.06), LEAF: 53.27 (+0.41), CMLS: 2.68 (+0.25), OGEN: 1.15 (-0.11), ALLB: 21.43 (+0.08)

Stocks Slip From Highs; Mylan Pulls Health Care Sector Lower
at The Street - Tue Mar 03, 10:28AM CST
Stocks fall back from records on Tuesday morning.
BCS: 15.32 (+0.35), MDR: 3.29 (+0.01), F: 16.48 (+0.14), GE: 25.40 (+0.07), DKS: 58.46 (+1.11), PFE: 34.25 (+0.10), C: 52.98 (+0.60), MYL: 63.06 (-0.88), BBY: 40.79 (-0.81), LL: 28.51 (-0.84), CELG: 128.50 (+3.17), AZO: 662.43 (-4.96), GILD: 102.29 (+0.85), GM: 38.87 (+0.22), LEAF: 53.27 (+0.41)

McDermott Turns Around with Solid Q4 Earnings, Shares Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 03, 10:00AM CST
McDermott International (MDR) reported strong fourth-quarter 2014 results owing to turnaround efforts.
VLP: 52.94 (+0.15), WGP: 60.99 (+0.57), MDR: 3.29 (+0.01), VTTI: 25.12 (+0.31)

McDermott (MDR) Stock Jumps on Earnings Beat
at The Street - Tue Mar 03, 9:05AM CST
McDermott (MDR) is gaining Tuesday after beating analysts' estimates in the fourth quarter.
MDR: 3.29 (+0.01)

Premarket Gainers / Losers as of 9:10 am
Seeking Alpha - at Seeking Alpha - Tue Mar 03, 8:16AM CST

MDR: 3.29 (+0.01), ONCY: 0.81 (-0.02), PLUG: 2.66 (-0.05), OCN: 8.52 (+0.17), XON: 46.11 (-1.26), TEDU: 10.39 (+0.16), BIOC: 2.45 (-0.12), LL: 28.51 (-0.84), MNKD: 5.26 (-0.28), CYCC: 0.98 (+0.02), CYTX: 1.19 (-0.03), DATE: 5.10 (unch), TSEM: 17.82 (-0.01), LEAF: 53.27 (+0.41), FNJN: 2.03 (-0.05), AMCO: 1.27 (+0.02)

Stock Futures Fall Back From Highs After Monday's Record Run
at The Street - Tue Mar 03, 7:11AM CST
Stock futures fall back from records on Tuesday morning, pointing to a weaker open.
BCS: 15.32 (+0.35), MDR: 3.29 (+0.01), AZO: 662.43 (-4.96), C: 52.98 (+0.60), BBY: 40.79 (-0.81)

McDermott International (MDR) David Dickson on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Mon Mar 02, 9:11PM CST

MDR: 3.29 (+0.01)

McDermott jumps on big Q4 earnings surprise, Middle East contracts
Seeking Alpha - at Seeking Alpha - Mon Mar 02, 5:49PM CST

MDR: 3.29 (+0.01)

After Hours Gainers / Losers
Seeking Alpha - at Seeking Alpha - Mon Mar 02, 4:37PM CST

GWRE: 53.65 (+0.84), MDR: 3.29 (+0.01), ST: 57.45 (+0.54), GRUB: 45.12 (-0.12), ISDR: 8.90 (+0.14), EWQ: 26.42 (+0.70), XON: 46.11 (-1.26), OPWR: 10.65 (+0.14), NSAM: 24.15 (-0.03), NE: 13.72 (+0.17)

McDermott International (MDR) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Mon Mar 02, 3:55PM CST

MDR: 3.29 (+0.01)

McDermott EPS of $0.03
Seeking Alpha - at Seeking Alpha - Mon Mar 02, 3:21PM CST

MDR: 3.29 (+0.01)

McDermott Reports Fourth Quarter and Full Year 2014 Financial Results
Business Wire - Mon Mar 02, 3:05PM CST
--New Business Partnerships with Industry Leaders
MDR: 3.29 (+0.01)

McDermott Awarded Initial Work for the Marjan Gas Oil Separation Plant (GOSP's) Power Supply Generation System Offshore Saudi Arabia
Business Wire - Mon Mar 02, 3:04PM CST
McDermott Middle East, Inc. (NYSE:MDR) ("McDermott"

announced today that it has been awarded initial work for a significant power supply system replacement contract by Saudi Aramco for the Marjan field, offshore Saudi Arabia. Work is expected to be executed through the fourth quarter of 2016 and will be included in McDermott's first quarter 2015 backlog.
MDR: 3.29 (+0.01)

McDermott Awarded Wellhead Jacket, Deck and Umbilical Project Offshore Qatar
Business Wire - Mon Mar 02, 3:03PM CST
McDermott International, Inc. (NYSE:MDR) ("McDermott"

announced today that it has been awarded a large project for a new jacket, temporary deck and replacement umbilical by Qatar Petroleum for the North Field Alpha gas development, offshore Qatar. Work is expected to be executed through the second quarter of 2016 and will be included in McDermott's first quarter 2015 backlog.
MDR: 3.29 (+0.01)

Notable earnings after Monday’s close
Seeking Alpha - at Seeking Alpha - Sun Mar 01, 4:35PM CST

MBI: 9.24 (+0.06), GWRE: 53.65 (+0.84), CODI: 16.94 (+0.27), MDR: 3.29 (+0.01), HTGC: 13.98 (+0.33), NBR: 13.15 (+0.36), NTRI: 20.56 (+0.45), XON: 46.11 (-1.26), STKL: 11.01 (+0.50), OPWR: 10.65 (+0.14), CZR: 9.44 (unch), PANW: 144.08 (-2.11), INN: 14.23 (+0.30), CMLS: 2.68 (+0.25), MTDR: 20.17 (+0.01), ARNA: 4.80 (-0.21), MCEP: 5.43 (+0.14), SLXP: 172.80 (+0.26), BALT: 1.38 (+0.14), MYL: 63.06 (-0.88), SN: 11.80 (+0.08), EPIQ: 18.31 (+0.04), CHUY: 22.74 (+0.18), DTSI: 34.06 (-0.15), PRAA: 54.72 (+1.16), HALO: 14.63 (-1.43), CIM: 3.23 (+0.03), CKEC: 34.55 (+0.78)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Championing Change: USTA Mid-Atlantic Gala's Impact

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Viking Ventures: Impacts of VK2735 on Obesity Examined

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

D-Wave Quantum Hit with Securities Fraud Lawsuit

A Legal Quagmire for D-Wave Quantum Investors Securities fraud lawsuits are like light in a dark alley—you need them when the truth's been stashed out of sight, but they illuminate the dirty and damp parts of investment strategies nobody wants to talk about. Right now, D-Wave Quantum Inc. is smack dab in the middle of such litigious action. If you had the misfortune of...

Beef 'O' Brady's Expands Into Tuscaloosa Market

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

IDEAYA's IDE101: A New Front in Cancer Battle

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...